Schedule 13G ownership disclosure

Verrica Pharmaceuticals Inc.

Security class unavailable

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
106,275,773
Percent of class
38.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-22-001917
Form type
SC 13G/A
Filer
Manning Paul B
CIK
CIK 1494695
Filed
Feb 14, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub